Cargando…
Correction to: Antifungal activity of silver nanoparticles on fungal isolates from patients of suspected mucormycosis
Autores principales: | Chatterjee, Kuhu, Taneja, Juhi, Khullar, Shilpa, Pandey, Anil Kumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9810561/ https://www.ncbi.nlm.nih.gov/pubmed/36324015 http://dx.doi.org/10.1007/s10123-022-00285-2 |
Ejemplares similares
-
Antifungal activity of silver nanoparticles on fungal isolates from patients of suspected mucormycosis
por: Chatterjee, Kuhu, et al.
Publicado: (2022) -
P086 Clinical outcome and in vitro antifungal susceptibility of clinical isolates of rhino-orbito-cerebral mycosis associated with post COVID 19 from North India
por: Taneja, Juhi, et al.
Publicado: (2022) -
P265 Phaeohyphomycosis caused by Rhinocladiella similis mimicking Sporotrichosis
por: Taneja, Juhi, et al.
Publicado: (2022) -
Pseudomonas indica-Mediated Silver Nanoparticles: Antifungal and Antioxidant Biogenic Tool for Suppressing Mucormycosis Fungi
por: Salem, Salem S., et al.
Publicado: (2022) -
Correction to: Biosynthesis and characterization of silver nanoparticles induced by fungal proteins and its application in different biological activities
por: Othman, Abdelmageed M., et al.
Publicado: (2020)